IndianOil launches STORM-X, a high-octane racing fuel produced in India for the first time. The fuel meets FIA specifications and will be used in national and international racing events.

Private equity and venture capital investments in India declined 40% to $27.9 billion in 2023, while exits reached $19.34 billion. Industry experts see a rebound in 2024.

The India Hydrogen Alliance (IH2A) has expanded its membership with seven new industry members, including Torrent Power, Synergen Projects, and Godawari Power and Ispat. The group is working to...

Alipay Singapore Holding, an arm of Alibaba, divested its entire 3.44% stake in Zomato for Rs 3,337 crore. This comes after SoftBank also sold its stake in Zomato.

Adani Wilmar reported a consolidated net profit of Rs 313.20 crore for the April-June quarter, a significant turnaround from a loss in the same period last year.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Adani Wilmar reported a consolidated net profit of Rs 313.20 crore for the April-June quarter, a significant turnaround from a loss in the same period last year.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...